Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -4 | -1 | -7 | -21 |
| Other Investing Activity | 0 | 30 | 0 | 118 | 0 |
| Investing Cash Flow | $-7 | $26 | $-1 | $111 | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 156 | N/A | 601 | N/A | 0 |
| Debt Repayment | 0 | -176 | 0 | -173 | 0 |
| Common Stock Issued | 38 | N/A | 0 | N/A | 0 |
| Other Financing Activity | 0 | 2,573 | 0 | -2 | 0 |
| Financing Cash Flow | $194 | $2,396 | $601 | $-175 | $0 |
| Exchange Rate Effect | -7 | -78 | 14 | -29 | 4 |
| Beginning Cash Position | 1,021 | N/A | N/A | 4,898 | 7,853 |
| End Cash Position | 1,620 | 1,021 | 1,782 | 3,729 | 4,898 |
| Net Cash Flow | $606 | $-4,413 | $1,768 | $-1,138 | $-2,959 |
| Free Cash Flow | |||||
| Capital Expenditure | -7 | -4 | -1 | -7 | -21 |
| Free Cash Flow | -7 | -4 | -1 | -7 | -21 |